Date Hour Room Track
04th December,2018 9:30-11:00 am Track 3

The seed investment market is comprised of players with varied degrees of specialisation, from totally agnostic players involved in multiple industries, to pure players focusing on specific therapeutic areas. Do most specialised funds attract the more generalist types in the financing rounds? What is the importance of the amount of seed investment today for cross-industry funds, 100% healthcare-oriented funds, and pure players in the biotech industry, respectively?

Jan Adams - EMBL Ventures
Jonathan Tobin - Arix Bioscience
Jeroen Bakker - Novo Seeds
Jean-Charles Brosse - Positive Capital
Jacky Vonderscher - ENYO Pharma
Joseph Wagman - SOSV

Continue your tour